The Israeli blood diagnostics company, Sight Diagnostics behind delivering lab-grade full blood count (FBC) results to emergency departments, has deployed Sight OLO at the John Radcliffe Hospital, Oxford University Hospitals NHS FT.
The deployment allows FBC testing for patients attending the emergency departments in the UK and is supporting the validation of an AI triage system for COVID-19....
Sight Diagnostics, an Israeli startup developing a machine-vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round.
According to the company, this newest raise brings its lifetime funding to more than $124 million.
WHAT IT DOES
Founded in 2011, Sight Diagnostics offers an...
Israeli blood testing startup Sight Diagnostics has announced a collaboration with Sheba Medical Center near Tel Aviv to mitigate the risk of contamination by COVID-19.
Sight’s OLO blood analyser will provide rapid complete blood count (CBC) results in a dedicated lab to process samples of COVID-19 patients who are being monitored and treated in a separate field hospital.
Prior to deploying OLO...
Blood-testing startup gets $27.8 million. Sight Diagnostics — an Israeli digital health company that offers small, fast, point-of-care complete blood count tests requiring only a fingerprick — has raised $27.8 million in Series C funding, including a $10 million strategic investment from consumer digital health fund Longliv Ventures. Other investors included Jack Nicklaus II, Steven Esrick and...
